🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Drug Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are urged to message these accounts privately for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of members share comparison images, administration instructions and assertions of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could result in users administering substances of unknown origin.

Some experts stated the demand for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, advertising, and customer regulations, risking penalties, prosecution or prison.

Platform Response and Content Elimination

According to TikTok, the platform has removed problematic content and banned associated hashtags and search suggestions. The company said it was committed to keeping the platform secure and investing in enhancing compliance measures.

Digital Trading Operations

Research also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, populated with images of weight loss, positive reviews and step-by-step guides for mixing or administering at home.

After minutes of entering one group, a vendor shared contact information, where the majority of transactions take place. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Product Information and Costs

Within these groups, posts display black plastic packages with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When questioned how long a pen should be used, vendors give conflicting responses varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Although the research behind retatrutide is sound, these online products may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially significant medical dangers”.